ARROWHEAD PHARMACEUTICALS IN's ticker is and the CUSIP is 04280A900. A total of 3 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $88,366 | -90.5% | 3,400 | -89.5% | 0.00% | -100.0% |
Q1 2024 | $926,640 | -31.2% | 32,400 | -26.4% | 0.00% | 0.0% |
Q4 2023 | $1,346,400 | -4.4% | 44,000 | -16.0% | 0.00% | -20.0% |
Q3 2023 | $1,407,988 | -35.3% | 52,400 | -14.1% | 0.01% | -28.6% |
Q2 2023 | $2,175,260 | +108.4% | 61,000 | +48.4% | 0.01% | +75.0% |
Q1 2023 | $1,043,940 | -71.3% | 41,100 | -54.1% | 0.00% | -50.0% |
Q4 2022 | $3,634,176 | +38.5% | 89,600 | +12.8% | 0.01% | +60.0% |
Q3 2022 | $2,624,000 | +18.1% | 79,400 | +25.8% | 0.01% | +66.7% |
Q2 2022 | $2,222,000 | -55.1% | 63,100 | -41.4% | 0.00% | -40.0% |
Q1 2022 | $4,949,000 | -45.7% | 107,600 | -21.7% | 0.01% | -28.6% |
Q4 2021 | $9,110,000 | +8.6% | 137,400 | +2.2% | 0.01% | -22.2% |
Q3 2021 | $8,391,000 | -19.1% | 134,400 | +7.3% | 0.01% | -30.8% |
Q2 2021 | $10,369,000 | +70.7% | 125,200 | +36.7% | 0.01% | +44.4% |
Q1 2021 | $6,074,000 | -72.8% | 91,600 | -68.6% | 0.01% | -76.9% |
Q4 2020 | $22,367,000 | +550.2% | 291,500 | +264.8% | 0.04% | +254.5% |
Q3 2020 | $3,440,000 | -52.7% | 79,900 | -52.5% | 0.01% | -67.6% |
Q2 2020 | $7,269,000 | +103.1% | 168,300 | +35.3% | 0.03% | +17.2% |
Q1 2020 | $3,579,000 | -52.9% | 124,400 | +3.8% | 0.03% | -44.2% |
Q4 2019 | $7,605,000 | +328.5% | 119,900 | +90.3% | 0.05% | +271.4% |
Q3 2019 | $1,775,000 | -31.3% | 63,000 | -35.4% | 0.01% | -39.1% |
Q2 2019 | $2,584,000 | +967.8% | 97,500 | +638.6% | 0.02% | +666.7% |
Q1 2019 | $242,000 | -62.6% | 13,200 | -74.7% | 0.00% | -50.0% |
Q4 2018 | $647,000 | -82.8% | 52,100 | -73.5% | 0.01% | -80.0% |
Q3 2018 | $3,767,000 | +50.4% | 196,500 | +6.7% | 0.03% | +42.9% |
Q2 2018 | $2,505,000 | +386.4% | 184,200 | +158.0% | 0.02% | +320.0% |
Q1 2018 | $515,000 | -35.1% | 71,400 | -66.9% | 0.01% | -16.7% |
Q4 2017 | $793,000 | -19.8% | 215,600 | -5.6% | 0.01% | -33.3% |
Q3 2017 | $989,000 | +389.6% | 228,400 | +109.5% | 0.01% | +350.0% |
Q1 2017 | $202,000 | +39.3% | 109,000 | +16.6% | 0.00% | +100.0% |
Q4 2016 | $145,000 | -82.4% | 93,500 | -16.4% | 0.00% | -88.9% |
Q3 2016 | $822,000 | +173.1% | 111,900 | +97.7% | 0.01% | +125.0% |
Q2 2016 | $301,000 | – | 56,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BOOTHBAY FUND MANAGEMENT, LLC | 165 | $1,047,000 | 0.09% |
GROUP ONE TRADING, L.P. | 119,900 | $7,605,000 | 0.05% |
SIMPLEX TRADING, LLC | 745 | $4,725,000 | 0.01% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |